Alzheimer’s disease (AD) is characterized by the spread of tau pathology throughout the
cerebral cortex. This spreading pattern was thought to be fairly consistent across individuals, …

Objectives: To estimate a regional progression pattern of amyloid deposition from cross-sectional
amyloid-sensitive PET data and evaluate its potential for in vivo staging of an …

Importance Plasma phosphorylated tau at threonine 181 (p-tau181) has been proposed as
an easily accessible biomarker for the detection of Alzheimer disease (AD) pathology, but its …

Alzheimer's disease is a progressive neurodegenerative disease that typically manifests
clinically as an isolated amnestic deficit that progresses to a characteristic dementia syndrome. …

Tau phosphorylated at threonine 181 (p-tau181) measured in blood plasma has recently
been proposed as an accessible, scalable, and highly specific biomarker for Alzheimer’s …

An international consensus report in 2019 recommended a classification system for limbic-predominant
age-related TDP-43 encephalopathy neuropathologic changes (LATE-NC). The …

Background An international Delphi panel has defined a harmonized protocol (HarP) for the
manual segmentation of the hippocampus on MR. The aim of this study is to study the …

Background There is growing evidence in the literature that the cholinergic basal forebrain
might be one of the earliest affected structures in Alzheimer’s disease (AD). Recent data …

… Michel J Grothe Michel J Grothe … Ray, Steven Bradburn, Christopher Murgatroyd, Umar
Toseeb, Pablo Mir, George K Kountouriotis, Stefan J Teipel, Michel J Grothe, In vivo cholinergic …

Tau and amyloid beta (Aβ) proteins accumulate along neuronal circuits in Alzheimer’s disease.
Unraveling the genetic background for the regional vulnerability of these proteinopathies …